OBEFAZIMOD IN PATIENTS WITH MODERATE-TO-SEVERE ULCERATIVE COLITIS: EFFICACY AND SAFETY ANALYSIS FROM THE 96-WEEK OPEN-LABEL MAINTENANCE PHASE 2B STUDY

Severine Vermeire  1     Josianne Nitcheu  2     Paul GINESTE  2     Sheldon Sloan  2     Hartmut Ehrlich  2     Bruce E. Sands  3    
1 University Hospitals Leuven, Leuven, Belgium
2 Abivax, Paris, France
3 Icahn School of Medicine at Mount Sinai, New York, United States

Topic
Endoscopy, Histopathology, IBD

Conference
UEG Week 2023

Citation
United European Gastroenterology Journal 2023; 11 (Supplement 8)


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Social Sharing